Pressotherapy Systems Market Outlook:
Pressotherapy Systems Market size was USD 256.4 million in 2025 and is expected to reach USD 408.1 million by the end of 2035, increasing at a CAGR of 5.3% during the forecast period, i.e., 2026-2035. In 2026, the industry size of pressotherapy systems is estimated at USD 269.9 million.
The market has achieved international traction, owing to factors including a rise in circulatory and lymphatic disorders, increased awareness, and technological innovation in device design. According to an article published by NLM in April 2022, pressotherapy systems constitute the capability to significantly reduce muscle soreness by 7% from 24 to 96 hours. Besides, during post-exercise (Po-E), the utilization of these systems assist in reducing the condition by 43%. Meanwhile, excessive exercise can lead to delayed onset muscle soreness (DOMS), leading to an increase in serum creatine kinase activity, which can be diminished by pressotherapy intervention by 63%, thus suitable for the market’s upliftment.
Moreover, the cause of cardiovascular disease (CVD) is also another driver for boosting the market demand. According to the 2025 WHO report, this particular disease is one of the leading causes of death, including an estimated 17.9 million lives globally. In addition, over 4 out of 5 CVD deaths take place, owing to heart strokes and attacks, and 1/3 of these deaths happen prematurely among people aged 70 years. Besides, the November 2024 WHO report indicated that more than 657 million people across 39 countries globally suffer from lymphatic filariasis, and over 9.7 billion cumulative treatments have been provided to reduce the transmission, which is yet another reason for augmenting the market’s demand.
Pressotherapy Systems Market - Growth Drivers and Challenges
Growth Drivers
- Positive influence on blood rheology and biochemical markers: The proven ability to improve blood rheology and biochemical markers is effectively driving the clinical implementation and the market growth. As per the September 2024 NLM article, a clinical study was conducted on 15 healthy women aged between 20 and 26 years. They underwent 10 lower limb pressotherapy treatments, each lasting for 30 minutes. The analysis of the study demonstrated rheological parameters ranging from 0.5 to 1.1, 4.2, 15.9, 30.9, and 60.0 indices of blood viscosity, thereby deliberately uplifting the overall market globally.
- Lymphedema incidence as a chronic disease: This particular disease occurs, owing to a surge in lymphatic fluid in the body, resulting in swelling, along with tissue and skin changes, which is positively impacting the market internationally. As per an article published by NLM in April 2023, primary lymphedema is extremely rare, affecting only 1 in 100,000 individuals globally, whereas secondary lymphedema is one of the common causes of the disease, and 1 in 1,000 people in America are affected. Besides, the case of head and neck cancer, soft and lymphatic tissue complications commence in first 18 months, and 90% of patients experience internal and external lymphedema, thus enhancing the demand for the market.
- Medicare policy shift and technical accessibility: The aspect of changes in reimbursement and regulations has increased the adoption of innovation for the market across different nations. For instance, as per the 2023 CMS report, NeuroNode utilizes the body’s 3D spatial movements to provide suitable control of therapy devices. These movements can be effectively detected even if there has been a reduction in the muscle’s ability to contract by an estimated 95%. Besides, there has been the provision of a two-metal radiation protection solution, which is available across 40% of hospitals in America, thereby denoting an optimistic approach for the market expansion.
Global Presence of Ischaemic Heart Disease Driving the Pressotherapy Market Demand
International Premature Death Probability Among Women, 2024
|
Regions/Countries |
Probability % |
|
Fiji |
17.8 |
|
India |
12.8 |
|
Mauritius |
10.3 |
|
Mongolia |
6.4 |
|
Sub-Saharan Africa |
3.0 |
|
Australia |
0.3 |
Source: NLM, January 2024
Gross Domestic Product (GDP) Impacting the Market
Proportion of Countries in Regions’ GDP Spend on Health, 2024
|
Regions |
Country Percentage (%) |
|
Central Europe, Eastern Europe, and Central Asia |
85 |
|
Latin America and Caribbean |
71 |
|
North Africa and Middle East |
53 |
|
Southeast Asia, East Asia, and Oceania |
50 |
|
Sub-Saharan Africa |
45 |
|
South Asia |
0 |
Source: NLM, January 2024
Challenges
- Complicated approvals and delays in regulations: The international market is readily suffering from a lengthy and fragmented administrative pathway. The aspect of continuous transition in regulatory policies has developed a series backlogs for CE certifications, which is negatively impacting the overall market. Besides, these delays are especially affecting small-scale manufacturers, who are witnessing MDR complexity. However, the FDA’s Breakthrough Device program is the ultimate solution to diminish long approval duration, particularly for innovative and cutting-edge systems like that of pressotherapy.
- Restricted insurance coverage: The presence of barriers in insurance coverage has developed substantial market accessibility gaps, which are negatively impacting the market globally. In developing economies, the situation is worse since pressotherapy devices have been excluded from public health coverage, especially across countries in Southeast Asia and Africa. This coverage barrier has resulted in clinical consequences, leading to uninsured patients and discontinuation of treatments, thus lowering the market’s exposure.
Pressotherapy Systems Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
5.3% |
|
Base Year Market Size (2025) |
USD 256.4 million |
|
Forecast Year Market Size (2035) |
USD 408.1 million |
|
Regional Scope |
|
Pressotherapy Systems Market Segmentation:
Distribution Segment Analysis
The direct sales (B2B) segment is expected to hold the largest share of 52.7% by the end of 2035. The segment’s growth is highly attributed to increased procurement from hospitals, rehabilitation centers, and specialty clinics. In addition, the segment is also thriving, owing to long-lasting contracts with institutional purchasing power, government tenders, and healthcare service providers. For instance, the majority of hospitals in Europe supply pressotherapy devices through B2B collaboration, while Medicaid and Medicare reimbursements in the U.S. have deliberately incentivized bulk orders. Besides, notable organizations are leveraging direct sales to provide personalized maintenance and solutions, thus suitable for the segment’s upliftment.
End user Segment Analysis
The hospitals segment is projected to account for the second-largest share of 47.3% during the forecast timeline. According to an article published by NLM in August 2024, a survey was conducted on 86 hospitals in Australia, wherein it was disclosed that facility-based pressure ulcer rates varied from 7.8% to 9.3%, 6.3%, and 7.4%, over the past years. Besides, in the U.S., approximately 2.5 million patients receive standard medical treatment for pressure injuries in hospital facilities, leading to an expense of USD 9.1 billion to USD 11.6 billion. Therefore, hospitals are considered the most suitable hub for aiding patients with diseases, which denotes a huge opportunity for market growth.
Product Segment Analysis
The pneumatic compression devices segment is anticipated to garner the third-largest share of 43.8% during the projected duration. This device has been developed, owing to its capability to duplicate the principles and process of manual lymphatic drainage (MLD). In this regard, the October 2022 NLM article conducted a clinical trial on 40 patients affected with lower limb ISL Stage II. These patients were divided into three categories, ranging from A, B, and C, and Group A patients demonstrated a diminish in limb volume by 38.4%. This was followed by Group B displaying a 13.1% reduction and 11.8% for Group C, thus proliferating the overall segment.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Distribution |
|
|
End user |
|
|
Product |
|
|
Application |
|
|
Technology |
|
|
Compression Type |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Pressotherapy Systems Market - Regional Analysis
North America Market Insights
North America market is anticipated to be the dominant region, with the highest share of 38.1% by the end of 2035. The market’s growth in the region is effectively fueled by an increase in chronic disease prevalence, an expansion in sports medicine, the demand for post-surgical rehabilitation, strong reimbursement support, and technological advancements. As per the October 2024 CDC report, 6 in 10 people in the region are affected by one chronic disease, and 4 out of 10 suffer from 2 chronic conditions. Additionally, diabetes, cancer, and heart disease are driving USD 4.9 trillion healthcare expenses in the U.S., thus suitable for the market’s development.
The pressotherapy systems market in the U.S. is gaining increased traction, owing to a surge in sports medicine demand and import and export facilities for valves. In this regard, the University of Western States, in its February 2025 article, stated that an estimated 30 million children in the country play sports, leading to an average of 3.5 million injuries every year during adolescence. Additionally, there has been an increase in students participating at the National Collegiate Athletic Association (NCAA) level by more than 3,000 athletes. Besides, as per the July 2025 OEC report, the country is the top exporter and importer of valves, with a valuation of USD 522 million and USD 559 million, as of 2023, thus catering to the market’s growth.
The pressotherapy systems market in Canada is also steadily growing due to the occurrence of non-communicable diseases and the provision of government funds and strategies. For instance, the October 2024 Pan American Health Organization data report stated that the tobacco prevalence in the country among more than 15 years of age was 12.0%, for which pressotherapy systems are implemented as a supportive therapy. Meanwhile, the May 2022 Government of Canada report noted that over 750,000 people are affected by heart failure, with approximately 100,000 new cases every year. To reduce this, the government made a provision of USD 5 million to develop a national research network to augment the prevention procedure.
Public Expenditure on Health in North America (2024)
|
Countries |
Expenditure (%) |
|
Cuba |
12.6 |
|
U.S. |
9.6 |
|
Canada |
8.0 |
|
Panama |
5.4 |
|
Jamaica |
5.1 |
|
Dominica |
4.2 |
|
Bahamas |
4.0 |
|
Mexico |
3.0 |
|
Saint Lucia |
2.6 |
|
Grenada |
2.2 |
|
Haiti |
0.4 |
Source: Pan American Health Organization, October 2024
APAC Market Insights
Asia Pacific market is projected to be the fastest-growing region, accounting for a share of 22.3% during the forecast period. The market’s upliftment in the region is attributed to an increase in venous diseases, a surge in medical tourism to ensure cost-effective therapies, an upsurge in the fitness industry, and expansion in private healthcare facilities. As per the August 2022 NLM article, the varicose vein disease, which is a type of venous disorder, prevalence rate is 18%, which is less in comparison to other nations. Additionally, the incidence rate in Japan was 45%, and 8.3% in China, thus denoting a huge demand for the market. Besides the October 2024, the Lancet Global Health article denoted that majority of the population spends 10% of yearly consumption expenditure on healthcare, which is also driving the market.
The pressotherapy systems market in China is gaining increased exposure, owing to modernization in government-supported healthcare services, the presence of regional MedTech manufacturing, and an increase in the aging population. As stated in the July 2023 NLM article, in 2022, Shanghai United Imaging Medical Technology Co., Ltd., successfully collaborated with Zhongshan Hospital to introduce the Time-of-Flight Intracranial MRA. This ensured scientific research and technological (Sci-tech) and digital health innovation in the medical field, particularly across different hospitals. Besides, 25% of hospitals in the country have better innovation performance, which is readily driving the market’s demand.
The pressotherapy systems market in India is also growing due to the presence of Ayushman Bharat coverage, an increase in the demand for portable devices, and the availability of equipment sourcing to check and measure pressure. According to the October 2024 India Government report, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) provided free health insurance coverage of Rs 5 lakh (USD 5,706) per family for senior citizens and ensured accessibility to the scheme’s benefits. Meanwhile, the 2023 OEC data report indicated that the country is the top importer of equipment, with a valuation of USD 179 million in 2023, with an ECI ranking of 39 out of 132, thus suitable for the market’s growth.
Lymphatic Fibrosis Incidence in Asia (2021)
|
Asia-Based Countries |
Prevalence % |
|
India |
2 to 21 |
|
Nepal |
13 |
|
Malaysia |
10 to 25 |
|
Indonesia |
9 to 20 |
|
Saudi Arabia |
4 |
|
Thailand |
0.3 |
|
Sri Lanka |
0.3 to 1.1 |
|
Cambodia |
0.5 |
Source: NLM, January 2021
Europe Market Insights
Europe in the pressotherapy systems market is expected to garner a considerable share of 28.4% by the end of the projected timeline. The market’s growth in the region is propelled by a surge in aging demographics, advancement in health and medical services, sports medicine availability, and growth in medical tourists. As stated in the December 2023 NLM report, over 1/5th of the population in Europe Union is aged more than 60 years, along with a ratio of 3 working-age people. In addition, elderly people are expected to constitute almost 1/3rd of the population by the end of 2050. This denotes a rise in chronic diseases, which in turn, enhances the demand for the market in the overall region.
The pressotherapy systems market in Germany is rapidly growing since there exists the provision of a healthcare budget, a robust MedTech sector, as well as reimbursement policies. According to a data report published by the ITA in August 2025, the country imported an estimated USD 3.1 billion of medical appliances and instruments from the U.S. This, in turn, led to an almost 2.0% of the international total for this category, which denotes a huge development for the market. Likewise, there has been a generous import of medical and technical apparatus to the country of worth USD 9.8 billion, thereby suitable for the market’s upliftment.
The pressotherapy systems market in the UK is significantly growing due to the existence of the NHS investment, extension in home care services, and post-Brexit policies. As per the June 2025 Government UK report, the provision of £6 billion investment ensured latest scanners, diagnostic capacities, emergency treatment centers, and ambulances. In addition, 92% of patients commenced with consult-based treatments within 18 weeks, and the 4 million additional tests, procedures, and scans are also available to them. Besides, there has been another investment of £30 billion for five years regarding the repairment and maintenance of the NHS estate, to ensure continuous funding provision, which creates a positive outlook for the market in the country.
Key Pressotherapy Systems Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The international pressotherapy systems market is severely competitive, owing to the existence of key players, such as Tactile Medical and DJO Global, collectively incorporating FDA-approved advancements, along with sports medicine collaborations and partnerships. In addition, organizations in Europe, including BSNL Medical, readily dominate clinical settings, while manufacturers from Asia, such as Kangzhu and Hanil, are effectively competing on affordability. Meanwhile, Omron in Japan is deliberately leading in home case devices, which in turn leverages artificial intelligence and robots, thereby suitable for bolstering the overall market globally.
Here is a list of key players operating in the global market:
|
Company Name (Country) |
Industry Focus |
Market Share (2024) |
|
Tactile Medical (U.S.) |
Leader in pneumatic compression for lymphedema; FDA-cleared Flexitouch system |
25.2% |
|
DJO Global (U.S.) |
Sports recovery & clinical compression devices; AirCompex line |
18.3% |
|
BSN Medical (Essity) (Germany) |
Gradient compression therapy; JOBST recovery systems |
15.7% |
|
Bio Compression Systems (U.S.) |
Medical-grade sequential compression devices |
12.1% |
|
Lympha Press (U.S.) |
Advanced sequential compression for lymphedema |
10.9% |
|
Medi GmbH (Germany) |
Medical compression garments & pumps |
xx% |
|
Sigvaris (Switzerland) |
Compression stockings & pneumatic devices |
xx% |
|
ArjoHuntleigh (Sweden) |
Hospital-grade pressotherapy for DVT prevention |
xx% |
|
Novamed (UK) |
Home-use pressotherapy devices |
xx% |
|
Compression Therapy Solutions (Australia) |
Clinical & aesthetic pressotherapy |
xx% |
|
Hanil Medical (South Korea) |
AI-powered compression systems |
xx% |
|
Airos Medical (U.S.) |
Portable compression devices |
xx% |
|
SunTech Medical (U.S.) |
Cardiovascular-focused compression tech |
xx% |
|
Kangzhu Medical (China) |
Low-cost pneumatic devices |
xx% |
|
Vissco Rehabilitation (India) |
Affordable compression therapy for emerging markets |
xx% |
Below are the areas covered for each company in the pressotherapy systems market:
Recent Developments
- In November 2024, Tampa General Hospital entered into a partnership with the University of South Florida to ensure next-generation medical devices in the Tampa Bay region.
- In September 2024, Ropirio Therapeutics, Inc. (Ropirio), in partnership with The Wyss Institute, received an exclusive license from Harvard’s Office of Technology Development (OTD) and Boston University (BU)’s Technology Development office to activate the lymphatic system.
- Report ID: 4388
- Published Date: Aug 19, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Pressotherapy Systems Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
